A review of acute cyanide poisoning with a treatment update

Critical Care Nurse

Volumn 31, Issue 1, 2011, Pages 72-82

  Hamel, Jillian ^a  

^a UNIVERSITY OF MARYLAND MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYANIDE;

ACUTE DISEASE; HUMAN; INTOXICATION; REVIEW;

ACUTE DISEASE; CYANIDES; HUMANS; POISONING;

EID: 79960882692     PISSN: 02795442     EISSN: None     Source Type: Journal    
DOI: 10.4037/ccn2011799     Document Type: Review

References (20)

1. Fortin JL, Giocanti JP, Ruttimann M, Kowalski JJ. Prehospital administration of hydroxocobalamin for smoke-inhalation associated cyanide poisoning: 8 years of experience in the Paris Fire Brigade. Clin Toxicol (Phila). 2006;44(suppl 1):37-44.
2. Borron SW, Baud FJ, Mégarbane B, Bismuth C. Hydroxocobalamin for severe acute cyanide poisoning by ingestion or inhalation. Am J Emerg Med. 2007;25(5):551-558.
3. Thompson RL, Manders WW, Cowan RW. Postmortem findings of the victims of the Jonestown tragedy. J Forensic Sci. 1987;32(2): 433-443.
4. DesLauriers CA, Burda AM, Wahl M. Hydroxocobalamin as a cyanide antidote. Am J Ther. 2006;13(2):161-165.
5. Hall AH, Dart R, Bogdan G. Sodium thiosulfate or hydroxocobalamin for the empiric treatment of cyanide poisoning? Ann Emerg Med. 2007;49(6):806-813.
6. Bronstein AC, Spyker DA, Cantilena LR Jr, et al; American Association of Poison Control Centers. 2007 Annual report of the American Association of Poison Control Centers' National Poison Data System NPDS: 25th annual report. Clin Toxicol (Phila). 2008;46(10):927-1057.
7. Borron SW. Recognition and treatment of acute cyanide poisoning. J Emerg Nurs. 2006; 32(4 suppl):S11-S18.
8. Schnepp R. Cyanide: sources, perceptions and risks. J Emerg Nurs. 2006;32(4 suppl):S3-S7.
9. Shepherd G, Velez L. Role of hydroxocobalamin in acute cyanide poisoning. Ann Pharmacother. 2008;42(5):661-669.
10. Barillo DJ. Diagnosis and treatment of cyanide toxicity. J Burn Care Res. 2009;30(1):148-152.
11. Smith D, Cairns B, Ramadan F, et al. Effect of inhalation injury, burn size, and age on mortality: a study of 1447 consecutive burn patients. J Trauma. 1994;37:655-659.
12. Benowitz NL. Antihyptertensive agents. In: Katzung BG, ed. Basic and Clinical Pharmacology. 10th ed. New York, NY: McGraw-Hill Co Inc; 2007:173-174.
13. Nelson L. Acute cyanide toxicity: mechanisms and manifestations. J Emerg Nurs. 2006; 32(4 suppl):S8-S11.
14. Koschel MJ. Management of the cyanidepoisoned patient. J Emerg Nurs. 2006;32(4 suppl):S19-S26.
15. Chen KK, Rose CL. Nitrite and thiosulfate therapy in cyanide poisoning. JAMA. 1952; 149:113-115.
16. US Food and Drug Administration. FDA news: FDA approves drug to treat cyanide poisoning. US Food and Drug Administration Web site. www.fda.gov/NewsEvents /Newsroom/PressAnnouncements/2006/ucm108807.htm. Published December 15, 2006. Updated June 18, 2009. Accessed October 29, 2010.
17. Cyanokit [package insert]. Columbia, MD: Meridian Medical Technologies Inc. http:// www.cyanokit.com/pdf/cyanokit_pi.pdf. Accessed October 29, 2010.
18. Uhl W, Nolting A, Golor G, Rost KL, Kovar A. Safety of hydroxocobalamin in healthy volunteers in a randomized, placebo-controlled study. Clin Toxicol (Phila). 2006;44(suppl 1): 17-28.
19. Dart RC. Hydroxocobalamin for acute cyanide poisoning: new data from preclinical and clinical studies; new results from the prehospital emergency setting. Clin Toxicol (Phila). 2006;44(suppl 1):1-3.
20. Borron SW, Baud FJ, Barriot P, Imbert M, Bismuth C. Prospective study of hydroxocobalamin for acute cyanide poisoning in smoke inhalation. Ann Emerg Med. 2007; 49(6):794-801.